United States

Vertex Pharmaceuticals Inc (VRTX.O)

VRTX.O on Nasdaq

17 Jan 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Jeffrey Leiden

60 2012 Chairman of the Board, President, Chief Executive Officer

Ian Smith

50 2017 Chief Financial Officer, Chief Operating Officer, Executive Vice President

Michael Parini

41 2017 Executive Vice President, Chief Legal and Administrative Officer

David Altshuler

51 2015 Executive Vice President - Global Research, Chief Scientific Officer

Stuart Arbuckle

50 2012 Executive Vice President, Chief Commercial Officer